Please Wait.....
Report
Netherlands Cell and Gene Therapy Business and Investment Opportunities Outlook - Q1 2023 Update
Market Report I 2023-02-22 I 51 Pages I BioIntel360
This report provides an in-depth, data-centric analysis of the Netherlands cell and gene therapy market 2018-2027. Below is a summary of key market segments:
Cell & Gene Therapy Market Size by Different Therapy Segment, 2018-2027
- Cell and Gene Modified Cell Therapies
- Gene Therapy and Genome Therapy
- DNA & RNA Therapeutics
Cell & Gene Therapy Market Size by Purpose of Manufacturing
- Commercial
- Clinical
Cell & Gene Therapy Market Size by Product
- Abecma
- Amondys
- Breyanzi
- Carvykti
- Givlaari
- Kimmtrak
- Kymriah
- Leqvio
- Luxturna
- Onpattro
- Oxlumo
- Rethymic
- Skysona
- Stratagraft
- Tecartus
- Tegsedi
- Viltepso
- Vyondys
- Yescarta
- Zolgensma
- Zynteglo
Cell & Gene Therapy Market Size by Route of Administration
- Injectables
- Infusions
- Bioscaffolds
- Topicals
Cell & Gene Therapy Market Size by Type of Cell
- CAR-T Cell
- TCR Cell
Cell & Gene Therapy Market Size by Type of Therapy
- T-Cell Therapies
- NK Cell
- Dendritic Cell Therapies
- Stem Cell Therapies
Cell & Gene Therapy Market Size by Source of Cell
- Autologous
- Allogenic
Cell & Gene Therapy Market Size by Delivery Mode
- In vivo
- ex-vivo
Cell & Gene Therapy Market Size by Source of Manufacturing
- In-House
- Contract Manufacturing
Cell & Gene Therapy Market Size by Therapeutic Class
- Oncology
- Neurology
- Ophthalmology
- Musculoskeletal
- Others
Cell & Gene Therapy Market Size by Technology
- Viral Vector Technology
- Cell Immortalization Technology
- Genome Editing Technology
- Others
Cell & Gene Therapy Market Size by End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospital & Clinics
1 Netherlands Cell and Gene Therapy Market Size and Forecast, 2018-2027
2 Netherlands Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027
2.1 Netherlands Market Size by Cell and Gene Modified Cell Therapies, 2018-2027
2.2 Netherlands Market Size by Gene Therapy and Genome Therapy, 2018-2027
2.3 Netherlands Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, 2018-2027
3 Netherlands Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027
3.1 Netherlands Cell and Gene Therapy Market Size by Commercial, 2018-2027
3.2 Netherlands Cell and Gene Therapy Market Size by Clinical, 2018-2027
4 Netherlands Cell and Gene Therapy Market Share by Product, 2018-2027
5 Netherlands Cell and Gene Therapy Market Share by Route of Administration, 2018-2027
5.1 Netherlands Cell and Gene Therapy Market Size by Injectables, 2018-2027
5.2 Netherlands Cell and Gene Therapy Market Size by Topicals, 2018-2027
5.3 Netherlands Cell and Gene Therapy Market Size by Infusions, 2018-2027
5.4 Netherlands Cell and Gene Therapy Market Size by Bioscaffolds, 2018-2027
6 Netherlands Cell and Gene Therapy Market Share by Type of Diseases, 2018-2027
6.1 Netherlands Cell and Gene Therapy Market Size by Rare Diseases, 2018-2027
6.2 Netherlands Cell and Gene Therapy Market Size by Non-Rare Diseases, 2018-2027
7 Netherlands Cell and Gene Therapy Market Share by Type of Cell, 2018-2027
7.1 Netherlands Cell and Gene Therapy Market Size by CAR-T Cell, 2018-2027
7.2 Netherlands Cell and Gene Therapy Market Size by TCR Cell, 2018-2027
8 Netherlands Cell and Gene Therapy Market Share by Therapy, 2018-2027
8.1 Netherlands Cell and Gene Therapy Market Size by T-Cell Therapies, 2018-2027
8.2 Netherlands Cell and Gene Therapy Market Size by NK Cell, 2018-2027
8.3 Netherlands Cell and Gene Therapy Market Size by Dendritic Cell Therapies, 2018-2027
8.4 Netherlands Cell and Gene Therapy Market Size by Stem Cell Therapies, 2018-2027
9 Netherlands Cell and Gene Therapy Market Share by Source of Cell, 2018-2027
9.1 Netherlands Cell and Gene Therapy Market Size by Autologous, 2018-2027
9.2 Netherlands Cell and Gene Therapy Market Size by Allogenic, 2018-2027
10 Netherlands Cell and Gene Therapy Market Share by Delivery Mode, 2018-2027
10.1 Netherlands Cell and Gene Therapy Market Size by In-vivo, 2018-2027
10.2 Netherlands Cell and Gene Therapy Market Size by Ex-vivo, 2018-2027
11 Netherlands Cell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027
11.1 Netherlands Cell and Gene Therapy Market Size by In-House, 2018-2027
11.2 Netherlands Cell and Gene Therapy Market Size by Contract Manufacturing, 2018-2027
12 Netherlands Cell and Gene Therapy Market Share by Therapeutic Class, 2018-2027
12.1 Netherlands Cell and Gene Therapy Market Size by Oncology, 2018-2027
12.2 Netherlands Cell and Gene Therapy Market Size by Neurology, 2018-2027
12.3 Netherlands Cell and Gene Therapy Market Size by Ophthalmology, 2018-2027
12.4 Netherlands Cell and Gene Therapy Market Size by Musculoskeletal, 2018-2027
12.5 Netherlands Cell and Gene Therapy Market Size by Others, 2018-2027
13 Netherlands Cell and Gene Therapy Market Share by Technology, 2018-2027
13.1 Netherlands Cell and Gene Therapy Market Size by Viral Vector Technology, 2018-2027
13.2 Netherlands Cell and Gene Therapy Market Size by Cell Immortalization Technology, 2018-2027
13.3 Netherlands Cell and Gene Therapy Market Size by Genome Editing Technology, 2018-2027
13.4 Netherlands Cell and Gene Therapy Market Size by Others Technologies, 2018-2027
14 Netherlands Cell and Gene Therapy Market Share by End User, 2018-2027
14.1 Netherlands Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, 2018-2027
14.2 Netherlands Cell and Gene Therapy Market Size by Academic & Research Institutes, 2018-2027
14.3 Netherlands Cell and Gene Therapy Market Size by Hospital & Clinics, 2018-2027
Table 1: Netherlands Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027
Table 2: Netherlands Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027
Table 3: Netherlands Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027
Table 4: Netherlands Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027
Table 5: Netherlands Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027
Table 6: Netherlands Cell and Gene Therapy Market Size by Clinical, by Value (USD MM) 2018-2027
Table 7: Netherlands Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027
Table 8: Netherlands Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027
Table 9: Netherlands Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027
Table 10: Netherlands Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027
Table 11: Netherlands Cell and Gene Therapy Market Size by Rare Diseases, by Value (UDS MM) 2018-2027
Table 12: Netherlands Cell and Gene Therapy Market Size by Non-Rare Diseases, by Value (UDS MM) 2018-2027
Table 13: Netherlands Cell and Gene Therapy Market Size by CAR-T Cell, by Value (UDS MM) 2018-2027
Table 14: Netherlands Cell and Gene Therapy Market Size by TCR Cell, by Value (UDS MM) 2018-2027
Table 15: Netherlands Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027
Table 16: Netherlands Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027
Table 17: Netherlands Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027
Table 18: Netherlands Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027
Table 19: Netherlands Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027
Table 20: Netherlands Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027
Table 21: Netherlands Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027
Table 22: Netherlands Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027
Table 23: Netherlands Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027
Table 24: Netherlands Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027
Table 25: Netherlands Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027
Table 26: Netherlands Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027
Table 27: Netherlands Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027
Table 28: Netherlands Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027
Table 29: Netherlands Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027
Table 30: Netherlands Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027
Table 31: Netherlands Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027
Table 32: Netherlands Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027
Table 33: Netherlands Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027
Table 34: Netherlands Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027
Table 35: Netherlands Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027
Table 36: Netherlands Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
Figure 1: Netherlands Cell and Gene Therapy Market Size by Value (USD MM) 2018-2027
Figure 2: Netherlands Cell and Gene Therapy Market Share by Different Therapy Segment (%), 2018-2027
Figure 3: Netherlands Cell and Gene Therapy Market Size by Cell and Gene Modified Cell Therapies, by Value (USD MM), 2018-2027
Figure 4: Netherlands Cell and Gene Therapy Market Size by Gene Therapy and Genome Therapy, by Value (USD MM) 2018-2027
Figure 5: Netherlands Cell and Gene Therapy Market Size by DNA & RNA Therapeutics, by Value (USD MM) 2018-2027
Figure 6: Netherlands Cell and Gene Therapy Market Share Purpose of Manufacturing (%), 2018-2027
Figure 7: Netherlands Cell and Gene Therapy Market Size by Commercial, by Value (USD MM) 2018-2027
Figure 8: Netherlands Cell and Gene Therapy Market Size, By Clinical, by Value (USD MM) 2018-2027
Figure 9: Netherlands Cell and Gene Therapy Market Share by Product (%), 2018-2027
Figure 10: Netherlands Cell and Gene Therapy Market Share by Route of Administration (%), 2018-2027
Figure 11: Netherlands Cell and Gene Therapy Market Size by Injectables, by Value (USD MM) 2018-2027
Figure 12: Netherlands Cell and Gene Therapy Market Size by Topicals, by Value (USD MM) 2018-2027
Figure 13: Netherlands Cell and Gene Therapy Market Size by Infusions, by Value (USD MM) 2018-2027
Figure 14: Netherlands Cell and Gene Therapy Market Size by Bio scaffolds, by Value (USD MM) 2018-2027
Figure 15: Netherlands Cell and Gene Therapy Market Share by Type of Diseases (%), 2018-2027
Figure 16: Netherlands Cell and Gene Therapy Market Share by Rare Diseases, by Value (UDS MM) 2018-2027
Figure 17: Netherlands Cell and Gene Therapy Market Share by Non-Rare Diseases, by Value (UDS MM) 2018-2027
Figure 18: Netherlands Cell and Gene Therapy Market Share by Type of Cell (%), 2018-2027
Figure 19: Netherlands Cell and Gene Therapy Market Share by CAR-T Cell, by Value (UDS MM) 2018-2027
Figure 20: Netherlands Cell and Gene Therapy Market Share by TCR Cell, by Value (UDS MM) 2018-2027
Figure 21: Netherlands Cell and Gene Therapy Market Share by Therapy (%), 2018-2027
Figure 22: Netherlands Cell and Gene Therapy Market Size by T-Cell Therapies, by Value (USD MM), 2018-2027
Figure 23: Netherlands Cell and Gene Therapy Market Size by NK Cell, by Value (USD MM), 2018-2027
Figure 24: Netherlands Cell and Gene Therapy Market Size by Dendritic Cell Therapies, by Value (USD MM), 2018-2027
Figure 25: Netherlands Cell and Gene Therapy Market Size by Stem Cell Therapies, by Value (USD MM), 2018-2027
Figure 26: Netherlands Cell and Gene Therapy Market Share by Source of Cell (%), 2018-2027
Figure 27: Netherlands Cell and Gene Therapy Market Size by Autologous (USD MM), 2018-2027
Figure 28: Netherlands Cell and Gene Therapy Market Size by Allogenic (USD MM), 2018-2027
Figure 29: Netherlands Cell and Gene Therapy Market Share by Delivery Mode (%), 2018-2027
Figure 30: Netherlands Cell and Gene Therapy Market Size by In-vivo, by Value (USD MM), 2018-2027
Figure 31: Netherlands Cell and Gene Therapy Market Size by Ex-vivo, by Value (USD MM), 2018-2027
Figure 32: Netherlands Cell and Gene Therapy Market Share by Source of Manufacturing (%), 2018-2027
Figure 33: Netherlands Cell and Gene Therapy Market Size by In-House, by Value (USD MM), 2018-2027
Figure 34: Netherlands Cell and Gene Therapy Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027
Figure 35: Netherlands Cell and Gene Therapy Market Share by Therapeutic Class (%), 2018-2027
Figure 36: Netherlands Cell and Gene Therapy Market Size by Oncology, by Value (USD MM), 2018-2027
Figure 37: Netherlands Cell and Gene Therapy Market Size by Neurology, by Value (USD MM), 2018-2027
Figure 38: Netherlands Cell and Gene Therapy Market Size by Ophthalmology, by Value (USD MM), 2018-2027
Figure 39: Netherlands Cell and Gene Therapy Market Size by Musculoskeletal, by Value (USD MM), 2018-2027
Figure 40: Netherlands Cell and Gene Therapy Market Size by Others, by Value (USD MM), 2018-2027
Figure 41: Netherlands Cell and Gene Therapy Market Share by Technology (%), 2018-2027
Figure 42: Netherlands Cell and Gene Therapy Market Size by Viral Vector Technology, by Value (USD MM), 2018-2027
Figure 43: Netherlands Cell and Gene Therapy Market Size by Cell Immortalization Technology, by Value (USD MM), 2018-2027
Figure 44: Netherlands Cell and Gene Therapy Market Size by Genome Editing Technology, by Value (USD MM), 2018-2027
Figure 45: Netherlands Cell and Gene Therapy Market Size by Others Technologies, by Value (USD MM), 2018-2027
Figure 46: Netherlands Cell and Gene Therapy Market Share by End User (%), 2018-2027
Figure 47: Netherlands Cell and Gene Therapy Market Size by Pharmaceutical & Biotechnology Companies, by Value (USD MM), 2018-2027
Figure 48: Netherlands Cell and Gene Therapy Market Size by Academic & Research Institutes, by Value (USD MM), 2018-2027
Figure 49: Netherlands Cell and Gene Therapy Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security